Iveda Solutions, Inc.
IVDA
Positions held
Your positionsIVDA isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $3.29M | Enterprise value | -$695,865 | Trailing P/E | — | Forward P/E | 0.14 |
| PEG | — | Price / book | 0.61 | Beta | 1.26 | Dividend yield | 0.00% |
| Revenue growth | -47.5% | Earnings growth | — | Gross margin | 32.2% | Operating margin | -88.6% |
| Profit margin | -69.2% | ROE | -91.9% | ROA | -34.4% | Debt / equity | 0.14 |
| Current ratio | 5.19 | Free cash flow | -$1.70M | Analyst recommendation | none | Mean target | — |
| 52w high | $1.52 | 52w low | $0.21 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.8M | $1.5M | $0.6M | $1.7M | $1.5M | — |
| Op margin | -88.6% | -37.9% | -262.7% | -13.0% | -34.8% | — |
| Net income | -$0.8M | -$0.5M | -$1.6M | -$0.2M | -$0.6M | — |
| Gross margin | 54.7% | 33.1% | 3.6% | 31.3% | 29.1% | — |
| Gross profit | $0.4M | $0.5M | $0.0M | $0.5M | $0.4M | — |
| Operating income | -$0.7M | -$0.6M | -$1.6M | -$0.2M | -$0.5M | — |
- Revenue -46% vs prior quarter ($0.8M vs $1.5M).
- Gross margin 54.7% (was 33.1% prior quarter).
- Operating margin compressed to -88.6%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $5.3M | $6.0M | $6.5M | $4.5M |
| Op margin | -61.1% | -67.6% | -62.2% | -74.5% |
| Net income | -$3.2M | -$4.0M | -$4.1M | -$3.3M |
| Gross margin | 24.1% | 21.6% | 16.4% | 21.6% |
| Gross profit | $1.3M | $1.3M | $1.1M | $1.0M |
| Operating income | -$3.2M | -$4.1M | -$4.0M | -$3.3M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · The Zacks Analyst Blog Highlights Advanced Micro Devices, Palo Alto, CnocoPhillips and Iveda
2026-10-07 · Top Stock Reports for AMD, Palo Alto & ConocoPhillips
2026-09-09 · NASDAQ Grants Iveda Additional 180-Day Period to Regain Minimum Bid Price Compliance
2026-08-28 · IVDA Stock Declines 43.4% as Q2 Loss Widens, Revenues Fall Y/Y
2026-08-13 · BC-Most Active Stocks
2026-08-13 · Top Premarket Gainers
2026-08-12 · GlobalMed® and Iveda Partner to Bring Intelligent, Mission-Ready Technology to Government Agencies
2026-08-05 · Iveda Leads the Way in EU AI Act Readiness for Europe’s $18B Video Intelligence Industry
2026-07-29 · Primion and Iveda Partner to Bring AI Vision Innovation to Converged Security Across Europe
Price (daily)
Full chart · RSI · MACD · patterns